Endo Pharma (ENDP) Tops Q1 EPS by 1c; Affirms Outlook
Tweet Send to a Friend
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) reported Q1 EPS of $1.09, $0.01 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
